Easton Historical Balance Sheet
| EAPH Stock | USD 0.0001 0.00 0.00% |
Trend analysis of Easton Pharmaceutica balance sheet accounts such as Other Liabilities of 250.1 K or Accounts Payable of 327.4 K provides information on Easton Pharmaceutica's total assets, liabilities, and equity, which is the actual value of Easton Pharmaceutica to its prevalent stockholders. By breaking down trends over time using Easton Pharmaceutica balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Financial Statement Analysis is much more than just reviewing and examining Easton Pharmaceutica latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Easton Pharmaceutica is a good buy for the upcoming year.
Easton Pharmaceutica Inventory |
|
Easton |
About Easton Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of Easton Pharmaceutica at a specified time, usually calculated after every quarter, six months, or one year. Easton Pharmaceutica Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Easton Pharmaceutica and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Easton currently owns. An asset can also be divided into two categories, current and non-current.
Easton Pharmaceutica Balance Sheet Chart
Add Fundamental
Total Assets
Total assets refers to the total amount of Easton Pharmaceutica assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Easton Pharmaceutica books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Current Liabilities
Total Current Liabilities is an item on Easton Pharmaceutica balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Easton Pharmaceutica are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Accounts Payable
An accounting item on the balance sheet that represents Easton Pharmaceutica obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Easton Pharmaceutica are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.Total Current Assets
The total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle.Net Invested Capital
The total amount of capital invested in a company, including both equity and debt, minus any cash or cash equivalents.Most accounts from Easton Pharmaceutica's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Easton Pharmaceutica current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Easton Pharmaceutica. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. For more detail on how to invest in Easton Stock please use our How to Invest in Easton Pharmaceutica guide.As of now, Easton Pharmaceutica's Other Current Assets are increasing as compared to previous years. The Easton Pharmaceutica's current Common Stock is estimated to increase to about 162.4 K, while Total Current Liabilities is projected to decrease to under 557.7 K.
| 2019 | 2020 | 2023 | 2024 (projected) | Total Current Liabilities | 1.5M | 620.8K | 558.7K | 557.7K | Total Assets | 17.2M | 10.2M | 11.7M | 12.3M |
Easton Pharmaceutica balance sheet Correlations
Click cells to compare fundamentals
Easton Pharmaceutica Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Easton Pharmaceutica balance sheet Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 2.6M | 10.1M | 17.2M | 10.2M | 11.7M | 12.3M | |
| Total Current Liabilities | 245.8K | 792.0K | 1.5M | 620.8K | 558.7K | 557.7K | |
| Other Liab | 48.3K | 46.2K | 161.1K | 180.2K | 162.1K | 250.1K | |
| Accounts Payable | 30.8K | 568.5K | 845.1K | 255.8K | 230.2K | 327.4K | |
| Total Liab | 2.5M | 3.0M | 10.1M | 3.3M | 3.8M | 2.0M | |
| Total Stockholder Equity | 160.0K | 7.1M | 7.1M | 6.9M | 7.9M | 8.3M | |
| Other Assets | 1.8M | 742.6K | 95.8K | 94.0K | 84.6K | 80.4K | |
| Net Tangible Assets | (465.0K) | (1.1M) | (1.1M) | (1.0M) | (930.6K) | (884.0K) | |
| Retained Earnings | (39.1M) | (39.2M) | (39.6M) | (39.8M) | (35.8M) | (37.6M) | |
| Long Term Debt | 2.2M | 2.2M | 8.5M | 2.5M | 2.9M | 1.9M | |
| Total Current Assets | 198K | 66.3K | 249.8K | 426.3K | 383.7K | 234.0K | |
| Long Term Investments | 926.6M | 1.1M | 1.7M | 1.7M | 1.6M | 1.5M |
Currently Active Assets on Macroaxis
When determining whether Easton Pharmaceutica offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Easton Pharmaceutica's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Easton Pharmaceutica Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Easton Pharmaceutica Stock:Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Easton Pharmaceutica. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. For more detail on how to invest in Easton Stock please use our How to Invest in Easton Pharmaceutica guide.You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Easton Pharmaceutica. If investors know Easton will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Easton Pharmaceutica listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Revenue Per Share 0.001 | Return On Assets (0.01) | Return On Equity (0.03) |
The market value of Easton Pharmaceutica is measured differently than its book value, which is the value of Easton that is recorded on the company's balance sheet. Investors also form their own opinion of Easton Pharmaceutica's value that differs from its market value or its book value, called intrinsic value, which is Easton Pharmaceutica's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Easton Pharmaceutica's market value can be influenced by many factors that don't directly affect Easton Pharmaceutica's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Easton Pharmaceutica's value and its price as these two are different measures arrived at by different means. Investors typically determine if Easton Pharmaceutica is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Easton Pharmaceutica's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.